1. Home
  2. JFU vs BRTX Comparison

JFU vs BRTX Comparison

Compare JFU & BRTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo 9F Inc.

JFU

9F Inc.

HOLD

Current Price

$6.31

Market Cap

58.2M

Sector

Finance

ML Signal

HOLD

Logo BioRestorative Therapies Inc. (NV)

BRTX

BioRestorative Therapies Inc. (NV)

HOLD

Current Price

$1.17

Market Cap

9.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
JFU
BRTX
Founded
2006
1997
Country
China
United States
Employees
N/A
N/A
Industry
Finance: Consumer Services
Managed Health Care
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
58.2M
9.7M
IPO Year
2019
N/A

Fundamental Metrics

Financial Performance
Metric
JFU
BRTX
Price
$6.31
$1.17
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
12.8K
30.8K
Earning Date
01-01-0001
11-12-2025
Dividend Yield
N/A
N/A
EPS Growth
3110.57
N/A
EPS
3.04
N/A
Revenue
$44,573,690.00
$383,400.00
Revenue This Year
N/A
$112.14
Revenue Next Year
N/A
$139.81
P/E Ratio
$2.31
N/A
Revenue Growth
8.19
1.70
52 Week Low
$1.01
$0.98
52 Week High
$9.48
$2.55

Technical Indicators

Market Signals
Indicator
JFU
BRTX
Relative Strength Index (RSI) 63.86 48.30
Support Level $5.92 $1.04
Resistance Level $7.76 $1.23
Average True Range (ATR) 0.95 0.08
MACD 0.06 0.02
Stochastic Oscillator 52.30 69.57

Price Performance

Historical Comparison
JFU
BRTX

About JFU 9F Inc.

9F Inc is a financial account platform integrating and personalizing financial services in China. It provides a range of financial products and services across online lending, wealth management, and payment facilitation, all integrated under a single digital financial account. The company's operations are organized into Material segments, consisting of E-commerce services, technology Empowerment service and Wealth Management services, of which it derives maximum revenue from technology Empowerment service. All its revenues are generated from the People's Republic of China.

About BRTX BioRestorative Therapies Inc. (NV)

BioRestorative Therapies Inc is a biotechnology company based in the United States. It focuses on the development of regenerative medicine products and therapies using cell and tissue protocols, involving adult (non-embryonic) stem cells. The company's two core development programs include the Disc/Spine Program, which involves cell therapy candidate, BRTX-100, a product formulated from autologous cultured mesenchymal stem cells collected from the patient's bone marrow; and the Metabolic Program, which includes the development of cell-based therapy to target obesity and metabolic disorders using brown adipose-derived stem cells, to generate brown adipose tissue.

Share on Social Networks: